Developer of proprietary and patented multi-chamber, sequential, dose syringe technology. The company develops syringe technology developed under its product name "ChaSyr" which allows for the sequential administration of two separate intravenous (IV) medications with a single syringe, replacing multiple syringes with just one.
Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
---|
This information is available in the PitchBook Platform. To explore Infusive Technologies‘s full profile, request access.
Request a free trialPublication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
---|---|---|---|---|---|
CA-2676248-A1 | Mixing syringe with and without flush | Abandoned | 23-Jan-2007 | 00000000000 | |
CA-2665697-A1 | Multi-chamber, sequential dose dispensing syringe | Abandoned | 10-Oct-2006 | 00000000000 | |
US-20060173439-A1 | Syringe drive system | Abandoned | 18-Jan-2005 | 0000000000 | 00 |
EP-1841475-A1 | Syringe drive system | Withdrawn | 18-Jan-2005 | 0000000000 | 0 |
EP-1841475-A4 | Syringe drive system | Withdrawn | 18-Jan-2005 | A61M5/1454 | 0 |
Name | Title | Board Seat | Contact Info |
---|---|---|---|
Gale Thorne Jr. | President & Chief Operating Officer |